Head-and-neck Squamous Cell Carcinoma Clinical Trial
Official title:
Phase II Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
The purpose of this study is to determine the diagnostic utility of 89Zr-panitumumab to identify metastatic lesion(s) in subjects with head and neck squamous cell carcinoma (HNSCC).
PRIMARY OBJECTIVE(S): - Determine the sensitivity and specificity of 89Zr-panitumumab for the detection of suspected metastatic lesions SECONDARY OBJECTIVE(S): - Compare sensitivity and specificity of 18F-FDG-PET/CT and 89Zr-panitumumab-PET/CT for detection of suspected metastatic lesions ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03396718 -
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
|
N/A | |
| Recruiting |
NCT01927354 -
Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.
|
N/A | |
| Completed |
NCT01941992 -
Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients
|
Phase 2 |